Health and Human Services Secretary Robert F. Kennedy Jr. further added to the Trump administration’s problematic claims ...
Kenvue, the American company that makes Tylenol, says the US Food and Drug Administration should not make proposed changes to ...
"Following the government’s recommendations to 'tough it out' ...could actually expose their fetus to the harms that they are ...
That slump has driven its dividend yield up to more than 5%. While Kenvue stock is down this year, it could soar in 2026.
Akron-based autism advocates are refuting claims by President Trump and Secretary Robert F. Kennedy Jr. that vaccines and ...
Kenvue, the owners of Tylenol, are pushing back on claims that acetaminophen—the chemical compound in their popular ...
Barchart on MSN
Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.
Kenvue (KVUE) could really use some good news. The Johnson & Johnson (JNJ) spinoff faced longlasting troubles regarding its ...
A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...
The severe stress caused by family upheaval might tax a child's immune system in ways that increase their chances of ...
Axios on MSN
Tylenol maker fights safety label change
The maker of Tylenol is pushing back against efforts to change the pregnancy warning on acetaminophen products, saying ...
3News launched a one hour noon news on Oct. 20 and The Daily Dose of Health News with Monica Robins is featured every day, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results